Abstract
Fibrin is the primary constituent of the vegetation in infective endocarditis, and tissue factor expression is a major mechanism of coagulation activation on infected valves. To determine which cells may participate in coagulation activation in this setting, expression of procoagulant activity (PCA; shown to be tissue factor) was studied in cultured endothelial and stromal cells derived from human cardiac valves. Endothelial cells had negligible PCA (99 +/- 50 mU/10(5) cells, mean +/- 1 standard deviation) unless stimulated by lipopolysaccharide or interleukin-1, which increased PCA to 5,592 +/- 1,482 and 5,901 +/- 1,497 mU/10(5) cells, respectively, in 6 h. Incubation of cells with viable enterococci or viridans streptococci or with an enterococcal cell wall preparation did not induce PCA. Cultured valve stromal cells constitutively expressed high levels of PCA (14,276 +/- 8,738 mU/10(5) cells) which was not changed with exposure to interleukin-1. PCAs of stromal or stimulated endothelial cells from valves of both right and left sides of the heart were comparable. The results suggest that endothelial cells may contribute to fibrin deposition during infection if stimulated, but PCA is not directly induced by bacteria. Stromal c...Continue Reading
References
Jul 1, 1979·Infection and Immunity·C J van GinkelW G van Aken
Mar 1, 1978·The Journal of Clinical Investigation·P K PetersonJ Verhoef
May 1, 1978·The Journal of Infectious Diseases·R J ElinS M Wolff
Jul 15, 1977·International Journal of Cancer. Journal International Du Cancer·E Engvall, E Ruoslahti
Jan 1, 1987·The Journal of Clinical Investigation·K L MooreN U Bang
Aug 1, 1986·The Journal of Clinical Investigation·M P BevilacquaD J Loskutoff
Feb 1, 1988·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·G M Rodgers
Apr 1, 1988·The Journal of Infectious Diseases·T A Drake, M Pang
May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·P P NawrothD M Stern
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·M P BevilacquaM A Gimbrone
Sep 1, 1986·Circulation Research·D A FilipM Simionescu
Nov 1, 1973·The Journal of Clinical Investigation·L W HoyerJ R Hoyer
Nov 1, 1973·The Journal of Clinical Investigation·E A JaffeR L Nachman
Oct 17, 1974·The New England Journal of Medicine·L Weinstein, J J Schlesinger
Jan 1, 1980·Methods in Cell Biology·G E StrikerS M Schwartz
Aug 1, 1984·The Journal of Experimental Medicine·M P BevilacquaM A Gimbrone
Jun 1, 1983·The Journal of Clinical Investigation·M ColucciN Semeraro
Jun 1, 1984·The Journal of Clinical Investigation·T A DrakeM A Sande
Nov 1, 1984·The New England Journal of Medicine·K M RowleyH S Cabin
Nov 11, 1983·Science·S C ThorntonE M Levine
Feb 1, 1982·Archives of Neurology·J BillerV J Howard
Citations
Feb 26, 2015·Journal of Tissue Engineering and Regenerative Medicine·Soumen JanaAmir Lerman
Jun 24, 1997·Proceedings of the National Academy of Sciences of the United States of America·J R ToomeyG J Broze
Sep 28, 1999·FEMS Microbiology Letters·D ChakravorttyT Yokochi
May 6, 2006·Tissue Engineering·Jonathan T Butcher, Robert M Nerem
Mar 31, 2004·Clinical Cardiology·N Semnur BuyukasýkDeniz Demirkan
Jul 27, 2004·Antimicrobial Agents and Chemotherapy·Michael R YeamanArnold S Bayer
Oct 19, 2000·Antimicrobial Agents and Chemotherapy·V K DhawanM R Yeaman
Nov 1, 1993·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·H FeiT A Drake
Jun 16, 2007·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Jonathan T Butcher, Robert M Nerem
Feb 13, 2002·Circulation·Leon Iri KupferwasserArnold S Bayer
Oct 26, 1999·Infection and Immunity·M H VeltropJ Thompson
Jun 25, 1998·Infection and Immunity·V K DhawanM R Yeaman
Dec 3, 1998·Antimicrobial Agents and Chemotherapy·A S BayerV G Fowler
Oct 15, 1998·Thrombosis Research·H KagawaS Fukuhara
Aug 1, 1992·Antimicrobial Agents and Chemotherapy·M R YeamanA S Bayer
Dec 1, 1993·Infection and Immunity·W V KernP Kern
Aug 1, 1994·Infection and Immunity·M R YeamanA S Bayer
May 1, 1994·Infection and Immunity·A L CheungA S Bayer
Aug 1, 1997·Infection and Immunity·V K DhawanA S Bayer
Sep 1, 1996·Infection and Immunity·S P KooA S Bayer
Apr 1, 1996·Infection and Immunity·M R YeamanA S Bayer
Nov 14, 1997·Infection and Immunity·A S BayerA L Cheung
Jul 1, 1994·Antimicrobial Agents and Chemotherapy·M R YeamanA S Bayer
Nov 14, 1997·Infection and Immunity·S P KooA S Bayer
Jun 1, 1992·Infection and Immunity·M R YeamanA S Bayer
Mar 1, 1992·Infection and Immunity·M R YeamanA S Bayer
Jul 3, 2002·Infectious Disease Clinics of North America·Philippe MoreillonArnold S Bayer
Mar 1, 1997·Infection and Immunity·M R YeamanM E Selsted